Richboro, PA, United States of America

Rene Braeckman

USPTO Granted Patents = 88 

 

Average Co-Inventor Count = 5.0

ph-index = 30

Forward Citations = 3,448(Granted Patents)


Inventors with similar research interests:


Location History:

  • Doylestown, PA (US) (2021)
  • Richboro, PA (US) (2012 - 2023)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Triglycerides
Cardiovascular Disease
Dyslipidemia
Hypertriglyceridemia
Apolipoprotein C-III
Nonalcoholic Steatohepatitis
Biliary Cirrhosis
High-Sensitivity C-Reactive Protein
Eicosapentaenoic Acid
Pharmaceutical Compositions
Statin Therapy
RLP-C
88 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rene Braeckman

Introduction: Rene Braeckman, hailing from Richboro, Pennsylvania, has made significant strides in the field of pharmaceuticals, particularly in the treatment of cardiovascular diseases. With an impressive portfolio of 88 patents, he has dedicated his career to developing innovative solutions that address critical health issues.

Latest Patents: Among his recent patents, two noteworthy inventions stand out. The first, titled "Compositions and methods for lowering triglycerides," provides innovative approaches for treating and preventing cardiovascular-related diseases in individuals in need. The second patent, "Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity," develops pharmaceutical compositions catering specifically to those with allergies, further demonstrating his commitment to inclusive healthcare solutions.

Career Highlights: Braeckman's career has been prominently associated with Amarin Pharmaceuticals, where he has worked with both Amarin Pharmaceuticals Ireland Limited and Amarin Pharma, Inc. His tenure at these organizations has allowed him to contribute significantly to cutting-edge research in cardiology and pharmaceutical formulation.

Collaborations: Throughout his career, Braeckman has collaborated with esteemed colleagues such as Paresh Soni and Pierre Wicker. These partnerships have fostered a creative environment that encourages innovative thinking and the development of groundbreaking medical solutions.

Conclusion: Rene Braeckman is a remarkable inventor whose contributions to the pharmaceutical industry have the potential to transform the treatment landscape for cardiovascular diseases. With his extensive patent portfolio and unwavering dedication to innovation, he continues to be a pivotal figure in advancing healthcare solutions that benefit numerous patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…